Literature DB >> 17131029

Chronic ocular surface disease after allogeneic bone marrow transplantation.

Mini Balaram1, Saadia Rashid, Reza Dana.   

Abstract

Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation (allo-BMT). Ocular surface disease (OSD) is one of the most common manifestations of chronic ocular GVHD, yet little is known about it. In this article, we review the available literature on this condition and present results from our study of the manifestations of OSD in the chronic phase (>3 months duration) post allo-BMT. Our study consisted of a retrospective chart review of 62 allo-BMT patients with chronic OSD evaluated at our center between 1995 and 2002. The clinical features, systemic associations, treatment, and status of OSD at the last follow-up are presented and discussed in the context of other reports of OSD in GVHD.

Entities:  

Year:  2005        PMID: 17131029     DOI: 10.1016/s1542-0124(12)70207-0

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  14 in total

1.  Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.

Authors:  Victor L Perez; Alexander Barsam; Stephanie Duffort; Maitee Urbieta; Henry Barreras; Casey Lightbourn; Krishna V Komanduri; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-01       Impact factor: 5.742

2.  Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.

Authors:  Kyung-Sun Na; Man Soo Kim
Journal:  J Ocul Pharmacol Ther       Date:  2012-06-25       Impact factor: 2.671

3.  Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy.

Authors:  Tudor C Tepelus; Gloria B Chiu; Jyotsna Maram; Jianyan Huang; Vikas Chopra; SriniVas R Sadda; Olivia L Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-05       Impact factor: 3.117

4.  Ocular complications in children after hematopoietic stem cell transplantation without total body irradiation.

Authors:  Michael Kinori; Bella Bielorai; Daniel Souroujon; Dafna Hutt; Iris Ben-Bassat Mizrachi; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-24       Impact factor: 3.117

5.  Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation.

Authors:  Hasanain Shikari; Francisco Amparo; Ujwala Saboo; Reza Dana
Journal:  Cornea       Date:  2015-03       Impact factor: 2.651

6.  Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.

Authors:  Rohan Bir Singh; Ann Yung; Giulia Coco; Shruti Sinha; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2020-07-30       Impact factor: 5.033

7.  Dry Eye Disease Incidence Associated with Chronic Graft-Host Disease: Nonconcurrent Cohort Study (An American Ophthalmological Society Thesis).

Authors:  Shahzad I Mian; Paola De la Parra-Colín; Rafael De Melo-Franco; Christopher Johnson; Tonatiuh Barrientos-Gutierrez
Journal:  Trans Am Ophthalmol Soc       Date:  2015-09

8.  Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation.

Authors:  K-S Na; Y-S Yoo; J W Mok; J W Lee; C-K Joo
Journal:  Bone Marrow Transplant       Date:  2015-08-24       Impact factor: 5.483

Review 9.  Foundational concepts in the biology of bacterial keratitis.

Authors:  Lawson Ung; James Chodosh
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

10.  Conjunctival Matrix Metalloproteinase-9 Clinical Assessment in Early Ocular Graft versus Host Disease.

Authors:  Luigi Berchicci; Emanuela Aragona; Alessandro Arrigo; Alessandro Marchese; Elisabetta Miserocchi; Francesco Bandello; Giulio Modorati
Journal:  J Ophthalmol       Date:  2021-06-12       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.